ESR1 polymorphism (rs2234693) influences femoral bone mass in patients with Turner syndrome (2019)
Scalco, Renata C; Trarbach, Ericka B; Albuquerque, Edoarda V. A; Homma, Thais K; Inoue-Lima, Thais H; Nishi, Mirian Y; Mendonça, Berenice Bilharinho de 
; Jorge, Alexander Augusto de Lima
Fonte: Endocrine connections. Unidade: FM
Assuntos: TRANSTORNOS DO DESENVOLVIMENTO SEXUAL, POLIMORFISMO, DENSIDADE ÓSSEA, MAMA, ÚTERO, TERAPIA DE REPOSIÇÃO DE ESTRÓGENOS, RECEPTORES DE ESTEROIDES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SCALCO, Renata C et al. ESR1 polymorphism (rs2234693) influences femoral bone mass in patients with Turner syndrome. Endocrine connections, v. 8, n. 11, p. 1513-1519, 2019Tradução . . Disponível em: https://doi.org/10.1530/EC-19-0398. Acesso em: 17 out. 2024.APA
Scalco, R. C., Trarbach, E. B., Albuquerque, E. V. A., Homma, T. K., Inoue-Lima, T. H., Nishi, M. Y., et al. (2019). ESR1 polymorphism (rs2234693) influences femoral bone mass in patients with Turner syndrome. Endocrine connections, 8( 11), 1513-1519. doi:10.1530/EC-19-0398NLM
Scalco RC, Trarbach EB, Albuquerque EVA, Homma TK, Inoue-Lima TH, Nishi MY, Mendonça BB de, Jorge AA de L. ESR1 polymorphism (rs2234693) influences femoral bone mass in patients with Turner syndrome [Internet]. Endocrine connections. 2019 ; 8( 11): 1513-1519.[citado 2024 out. 17 ] Available from: https://doi.org/10.1530/EC-19-0398Vancouver
Scalco RC, Trarbach EB, Albuquerque EVA, Homma TK, Inoue-Lima TH, Nishi MY, Mendonça BB de, Jorge AA de L. ESR1 polymorphism (rs2234693) influences femoral bone mass in patients with Turner syndrome [Internet]. Endocrine connections. 2019 ; 8( 11): 1513-1519.[citado 2024 out. 17 ] Available from: https://doi.org/10.1530/EC-19-0398
